The Problem
Today's AI systems make high-stakes decisions--across global security, finance, medicine, and more--without internal deliberation or ethical transparency. These opaque decision paths undermine public trust, expose organizations to regulatory risk, and increase the likelihood of harmful, unintended outcomes.
TransAI is an early stage start-up, building the first governance-layer infrastructure for AI designed to deliver transparent, traceable rationals for every decision. We target a specific B2B SaaS vertical: AI governance in high-stakes, compliance-heavy sectors such as healthcare, biotech, foreign policy, and finance. Our platform integrates directly into internal decision-making and advisory workflows, helping organizations manage algorithmic bias, auditability, and regulatory oversight--without micromanagement.
Our Solution
TransAI introduces a patent pending architecture including a deliberation engine that takes account of diverse cognitive and ethical perspectives; a petition and arbitration interface for human oversight at key junctures; a traceability layer for audit-ready decision histories; a dual track deployment with AI models based on proprietary deliberative committees of real historical personas or fully synthetic constructs.
Differentiators
Unlike other AI governance frameworks that rely on static policies, post-hoc explainability tools, or external oversight panels, TransAI embeds governance within the AI itself--through internal deliberation, cognitive maturation, and structured ethical memory. This allows decisions to be explained, audited and challenged from within, offering real-time transparency and accountability not available in conventional black-box systems.
Why Now? Why Us?
TransAI's Founding team and advisors combine unparalleled depth in AI, ethics, and large-scale systems with proven leadership in both industry and academia. Collective expertise spans pharmaceutical innovation, quantitative finance, high-performance computing, applied mathematics and biomedical research--fields where trust, transparency, and ethical rigor are essential.
Founder and CEO: Charles DeLisi, Dean emeritus of Boston University's College of Engineering and Metcalf Professor of Science and Engineering (1999-2024) is a pioneer in computational science and a transformative leader. Widely recognized as the ‘Father of the Human Genome Project’ he also initiated its ethical, legal and social implications program, now a global model for scientific foresight.
https://clintonwhitehouse5.archives.gov/WH/new/html/Mon_Jan_8_141714_2001.
html
https://www.dropbox.com/sel/fi/zb7j819gwa43s6q2r9vkg/Pitch.pptx?rlkey=epiy9oi05espqqz9crtdtyvv1&d1=0
Board of Advisors
Sorin Alexe — Successful hedge fund manager with 20+ years in ML software development, blending deep technical expertise with data-driven investment strategy.
Dileep Bhattacharia — 20 years in leadership roles at IBM Systems Technology Group, developing products in analytics, AI, and supercomputing, founder of DeNovo Analytics, a risk management company.
Dustin Holloway — Vice President and Global Head of Responsible Innovation at Sanofi Pharmaceuticals; former Director and Global Lead for AI & Technology Ethics at Takeda. Brings hands-on experience building and governing AI in highly regulated industries.
Mark Kon — Professor of Mathematics & Statistics; leading authority in machine learning, with decades of contributions to theory and applications.
Sir Richard Roberts—Dr. Roberts was co-recipient of the 1992 Nobel Prize in Physiology or Medicine. He will play a central role in developing TransAI strategy in
the medical arena.
Peter Wright — Experienced manager and Wharton-trained economist; founder of a profitable AI-driven company, known for creative, practical execution.
Zhiping Weng — Li Weibo Professor of Biomedical Research and founding Chair of Genomics & Computational Biology at UMass Medical School. She is internationally recognized for applying ML to complex biological systems; Chair of the SAB at Rgenta, a biotech startup.
This combination of scientific leadership, operational execution, and ethical AI governance positions TransAI to build the world’s most trusted AI decision-making platform.
Vision Statement: How TransAI Will Impact the World https://www.dropbox.com/scl/fi/dxiq96ra22271cw29sfxd/film.mp4?rlkey=ia8ycpogwt81lrauqvn8gjt6c&dl=0
Get in Touch
Contact us for detailed information on how TransAI can enhance your projects.